Federal judge bans Shkreli from pharma industry

Former pharmaceutical executive Martin Shkreli’s anticompetitive scheme to maintain a monopoly over a lifesaving parasitic treatment was so egregious he must be banned from the industry for life, a New York federal court has ruled.

Get unlimited access to all Global Competition Review content